Five things for pharma marketers to know: Tuesday, July 24, 2018

Share this content:

For some Medicare patients, using Wal-Mart's $4 prescription drug program is a more affordable option than their health insurance, according to a study published in the Annals of Internal Medicine. The researchers found that 21% of Medicare plans required patients to pay more out-of-pocket than they would have if they'd filled their prescription at Wal-Mart. (NBC News)

 

Bristol-Myers Squibb said on Monday that Murdo Gordon, chief commercial officer, will leave the company this summer for a new job. The drugmaker did not say where Gordon's next role will be. (Xconomy)

 

The Trump administration is pushing back against World Health Organization guidelines on antibiotic use in farm animals. The guidelines bar their use on healthy animals to promote faster growth or prevent disease. Developed by a panel of experts over a two-year period, the standards are meant to reduce the overuse of antibiotics, which has led to the rise of drug-resistant bacteria. The Agriculture Department has said the guidelines are “not supported by sound science.” (Bloomberg)

 

GlaxoSmithKline's two-drug HIV regimen is as effective as the standard triple therapy, according to pooled data from two late-stage clinical trials. The treatment combines dolutegravir and lamivudine. (Reuters)

 

Pharmaceutical and medical-device companies invested $739 million in medical education last year, according to an annual report from the Accreditation Council for Continuing Medical Education. That figure represented 28% of the total funding for continuing medical education last year. (MM&M)

Share this content:
Scroll down to see the next article